comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-12 08:30:41 - browse：87

Neumora, a privately held biotech company, is moving into the final phase of testing with a novel treatment for depression that showed promise in a mid-stage trial.

The drug, a daily pill called navacaprant, led to statistically significant improvements over placebo on a measurement of disease severity for patients with moderate to severe major depressive disorder, Neumora said Tuesday. In the eight-week study, the medicine also led to improvements in patient-reported anhedonia, a reduced ability to experience pleasure that often accompanies severe depression.

Navacaprant’s statistically significant benefits came from a pre-specified subset of 100 patients in a study that enrolled 171 people. In the total population, including 71 patients who had mild to moderate disease, navacaprant’s effect on depressive symptoms was numerically superior to placebo but did not reach the threshold of statistical significance, missing the study’s primary endpoint.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Wikipedia

WSS

Coercive sterilizations revealed by STAT prompt outrage

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

US intelligence assessment says Iran not currently developing nuclear weapons

Neutralizing antibodies against HIV shows promise in children

Study: Why relieving medical debt did not improve financial outcomes

My daughter's legacy lives on through her writing, phage therapy

explore

comprehensive

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Wildfire smoke exposes gaps in outdoor worker protections

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Curing rare childhood diseases will falter unless Congress steps up

DIEP, the 'gold standard' of breast reconstruction, is under threat

North Korean leader's powerful sister says warplanes repelled US spy plane

Supreme Court strikes down use of affirmative action

What to know about a major upcoming Wegovy heart health study

leisure time

Why Titanic fascinates society, still drawing tours to the wreckage

New report analyzes digital physical therapy solutions' effectiveness

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Deposition: Sackler embraced plan to conceal OxyContin’s strength

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Neutralizing antibodies against HIV shows promise in children

explore

leisure time

Wikipedia

leisure time